scholarly article | Q13442814 |
P50 | author | David J. Waxman | Q30506493 |
P2093 | author name string | Chen L | |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cancer gene therapy | Q124350675 |
gene therapy | Q213901 | ||
chemotherapy | Q974135 | ||
P304 | page(s) | 581-589 | |
P577 | publication date | 1995-02-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy | |
P478 | volume | 55 |
Q26860729 | Adenoviral vectors for prodrug activation-based gene therapy for cancer |
Q35768314 | Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter |
Q32117273 | Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites |
Q41349050 | Direct cell killing by suicide genes |
Q30842293 | Encapsulated cells expressing a chemotherapeutic activating enzyme allow the targeting of subtoxic chemotherapy and are safe and efficacious: data from two clinical trials in pancreatic cancer |
Q39713581 | Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA. |
Q37037051 | Enhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model |
Q35118933 | Gene therapy and targeted toxins for glioma |
Q57006162 | Gene therapy and targeted toxins for glioma |
Q33995752 | HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications |
Q41897991 | Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase |
Q90645513 | Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics |
Q33901287 | Metabolism and pharmacokinetics of oxazaphosphorines |
Q34749403 | Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo |
Q42137028 | Mouse mammary tumor virus promoter-containing retroviral promoter conversion vectors for gene-directed enzyme prodrug therapy are functional in vitro and in vivo |
Q39916257 | Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer |
Q24792836 | Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy) |
Q73429925 | Prodrugs in Cancer Chemotherapy |
Q35972548 | Self-assembled mPEG-PCL-g-PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro |
Q41030442 | The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions |
Search more.